3 updates on Orthofix shares

Spinal Tech

In August, Jefferies reiterated Orthofix's "buy" rating, according to News Den.

Here are three updates:


1. Jeffries presently has a $48 price target on Orthofix shares.


2. In July, Sidoti gave the shares a "buy rating."


3. Sidoti has a $43 price target on the company's shares.


More device news:
Titan Spine launches nanoLOCK surface technology nationwide: 5 highlights
Dr. Steven C. Schallhorn tapped as CMO of global ophthalmic devices for Carl Zeiss Meditec: 3 thoughts
Medtronic, Depuy Synthes lead cervical total disc replacement device market: 6 observations

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers